Mefenamic acid

Chemical formula: C₁₅H₁₅NO₂  Molecular mass: 241.285 g/mol  PubChem compound: 4044

Therapeutic indications

Mefenamic acid is indicated for:

Rheumatoid arthritis

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Rheumatoid arthritis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Primary dysmenorrhoea

Population group: women, only adolescents (12 years - 18 years old) , adults (18 - 65 years old)

Primary dysmenorrhea

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Menorrhagia and intrauterine devices (ΙUD)

Population group: women, only adults (18 - 65 years old)

Menorrhagia due to dysfunctional causes and presence of an IUD when other pelvic pathology has been ruled out.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Osteoarthritis

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Osteoarthritis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Pain

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Pain

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Headache

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Headache

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Pyrexia

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)

Fever

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Migraine

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Migraine

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Mefenamic acid is contraindicated in the following cases:

Pregnancy

Pregnancy

Perioperative pain after coronary artery bypass surgery (CABG)

Postoperative pain and additionally Repair of coronary artery

Severe heart failure

Heart failure New York Heart Assosiation Class IV

Peptic ulcer

Peptic ulcer

Gastro-intestinal bleeding

Gastrointestinal hemorrhage

Inflammatory bowel disease

Inflammatory disorder of digestive tract

Hepatic failure

Hepatic insufficiency

Renal failure

Renal failure

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2022: MEFENAMIC ACID Oral suspension
Summary of Product Characteristics (SPC) 2021: PONSTAN FORTE Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈